Correction: Jain et al. Proteomic Approach for Comparative Analysis of the Spike Protein of SARS-CoV-2 Omicron (B.1.1.529) Variant and Other Pango Lineages. 2022, , 34.

In the publication [...

Proteomic Approach for Comparative Analysis of the Spike Protein of SARS-CoV-2 Omicron (B.1.1.529) Variant and Other Pango Lineages.

The novel SARS-CoV-2 variant, Omicron (B.1.1.

Exotic magnetic behaviour and evidence of cluster glass and Griffiths like phase in Heusler alloys FeMnCrAl (0 ≤ x ≤ 1).

We present a detailed study of structural, magnetic and thermodynamic properties of a series of Heusler alloys FeMnCrAl (x = 0, 0.25, 0.5, 0.

Vinyl cyanide (CHCHCN) in interstellar space: potential spectral lines for its detection.

Vinyl cyanide is a molecule having planar geometry with electric dipole moment components, and . Thus, -type transitions are very strong as compared to -type transitions, and are considered in this investigation. The rotational levels for -type transitions, may be divided into two distinct groups: one group having odd values of and the other having even values of .

Complex magnetic behaviour and evidence of a superspin glass state in the binary intermetallic compound ErPd.

The binary intermetallic compound ErPd has been investigated using dc and ac magnetic susceptibilities, magnetic memory effect, isothermal magnetization, non-linear dc susceptibility, heat capacity and magnetocaloric effect studies. Interestingly, even though the compound does not show geometrical frustration it undergoes glassy magnetic phase transition below 17.2 K.

A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease.

The incretins glucagon-like peptide 1 (GLP-1) and glucose dependent insulinotropic polypeptide (GIP) are growth factors that have shown neuroprotective effects in animal models of Parkinson's and Alzheimer's disease. In addition, the GLP-1 mimetic exendin-4 has shown protective effects in a clinical trial in Parkinson's disease (PD) patients. GLP-1 analogues are currently on the market as treatments for type II diabetes.

Enhancement of magnetic ordering temperature and magnetodielectric coupling by hole doping in a multiferroic DyFeCrO.

We report the results of our investigation of magnetic, thermodynamic and dielectric properties of Ca substituted half-doped orthochromite, DyCaFeCrO. Magnetic susceptibility and heat capacity data bring out that this compound undergoes two antiferromagnetic transitions, one at ~132 and the other at ~22 K. These values are higher than those of DyFeCrO.

Effect of rare-earth (Er and Gd) substitution on the magnetic and multiferroic properties of DyFe0.5Cr0.5O3.

We report the results of our investigations on the influence of partial substitution of Er and Gd for Dy on the magnetic and magnetoelectric properties of DyFe0.5Cr0.5O3, which is known to be a multiferroic system.

Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells.

Currently, there is no viable treatment available for Parkinson's disease (PD) that stops or reverses disease progression. Interestingly, studies testing the glucagon-like-peptide-1 (GLP-1) mimetic Exendin-4 have shown neuroprotective/neurorestorative properties in pre-clinical tests and in a pilot clinical study of PD. Incretin analogues were originally developed to treat type 2 diabetes and several are currently on the market.

Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress.

Glucagon-like peptide 1 (GLP-1) is a growth factor that has demonstrated neuroprotective properties in a range of studies. In an APPswe/PS1ΔE9 mouse model of Alzheimer's disease (AD), we previously found protective effects on memory formation, synaptic plasticity, synapse survival and a reduction of amyloid synthesis and plaque load in the brain. Here, we analyse the neuroprotective properties of the GLP-1 analogue liraglutide in human neuroblastoma cell line SH-SY5Y during methyl glyoxal stress.

Development of a high-throughput screen targeting caspase-8-mediated cleavage of the amyloid precursor protein.

Caspases, effectors of apoptosis, are key mediators of neuronal death in several neurodegenerative diseases. Caspase-8 and caspase-6 have been implicated in the pathogenesis of amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, and Alzheimer's disease (AD). ß-Amyloid precursor protein (APP) is cleaved at Asp664 in its intracellular domain by caspase-8.

Extracellular glutamate alters mature osteoclast and osteoblast functions.

Glutamatergic intercellular communication is involved in many aspects of metabolic homeostasis in normal bone. In bone metastasis, the balance between bone formation and degradation is disrupted. Although the responsible mechanisms are not clear, we have previously identified that cancer cell lines used in bone tumour models secrete glutamate, suggesting that tumour-derived glutamate may disrupt sensitive signalling systems in bone.

A by-product of glutathione production in cancer cells may cause disruption in bone metabolic processes.

Bone is a frequent site for metastasis of breast and prostate cancers, often resulting in pathologic changes in bone metabolism and severe pain. The mechanisms involved are not well understood, but tumour cells may release factors that interfere with bone homeostasis. Several observations have led us to hypothesize that the functional disruptions in bone metastasis are the result of a biological process common to many cell types.

Cancer cells release glutamate via the cystine/glutamate antiporter.

Although the amino acid glutamate is used as an intercellular signaling molecule for normal bone homeostasis, little is known regarding its possible role in the metabolic disruption characteristic of bone metastasis. We have previously shown in vitro that cancer cell lines relevant to bone metastasis release glutamate into the extracellular environment. This study demonstrates the expression of multiple glutamate transporters in cancer cell lines of non-central nervous system origin.

Cancer cell lines release glutamate into the extracellular environment.

Bone is one of the most frequent sites for metastasis of breast and prostate cancers. Bone metastases are associated with pathologic changes in bone turnover and severe pain. The mechanisms that trigger these effects are not well understood, but it is postulated that tumour cells release factors which interfere with signalling processes critical to bone homeostasis.

A semi-quantitative GeLC-MS analysis of temporal proteome expression in the emerging nosocomial pathogen Ochrobactrum anthropi.

Background: The alpha-Proteobacteria are capable of interaction with eukaryotic cells, with some members, such as Ochrobactrum anthropi, capable of acting as human pathogens. O. anthropi has been the cause of a growing number of hospital-acquired infections; however, little is known about its growth, physiology and metabolism.